Trials / Completed
CompletedNCT05537675
Semi-automated Segmentation Methods of SSTR PET for Dosimetry Prediction
Semi-automated Segmentation Methods of SSTR PET for Dosimetry Prediction in Refractory Meningiomas Treated by SSTR-targeted Peptide Receptor Radionuclide Therapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Tumor dosimetry with somatostatin receptor-targeted peptide receptor radionuclide therapy (SSTR-targeted PRRT) by 177Lutetium-DOTATATE might contribute to improve follow-up and treatment response of refractory meningiomas. This study aims to evaluate Standard Uptake Value mean (SUVmean) as a tumoral absorbed dose predictive predictive factor and propose semi-automated segmentation method to determine metabolic tumor volume with pretherapeutic 68-Gallium-DOTATOC PET.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | To evaluate the SUVmean (Standard Uptake Value) as a predictive factor of the tumor absorbed dose compared to the SUVmax | Measure SUVmean (Standard Uptake Value) and SUVmax on PET exams |
Timeline
- Start date
- 2022-10-01
- Primary completion
- 2022-11-06
- Completion
- 2022-11-30
- First posted
- 2022-09-13
- Last updated
- 2023-11-30
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05537675. Inclusion in this directory is not an endorsement.